Defect Score of BMIPP or MIBG
Patient no. | Before treatment | After treatment | % Improvement (BMIPP/MIBG) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Vasospasm artery | Reduced wall motion | TDS (BMIPP/MIBG) | Vasospasm artery | Reduced wall motion | TDS (BMIPP/MIBG) | ||||||
Group I (n = 6) | |||||||||||
1 | LAD, LCX, RCX | — | 16/34 | LAD, LCX, RCX | — | 11/24 | 31/29 | ||||
2 | LAD, LCX, RCX | LAD, RCX | 23/38 | LAD, LCX, RCX | — | 19/34 | 17/11 | ||||
3 | LAD, LCX, RCX | LAD | 10/18 | RCX | — | 8/15 | 20/17 | ||||
4 | LAD, LCX, RCX | LAD, LCX, RCX | 15/27 | LAD | LAD | 12/25 | 20/7 | ||||
5 | LAD, LCX, RCX | — | 8/26 | LCX, RCX | — | 5/20 | 38/23 | ||||
6 | LCX | LCX | 8/28 | LCX | LCX | 6/26 | 25/7 | ||||
Mean ± SE | 13.3 ± 2.6/28.5 ± 3.1 | 10.2 ± 2.3/24.0 ± 2.8 | 25 ± 4/ 16 ± 4 | ||||||||
Group II (n = 10) | |||||||||||
1 | LAD, LCX, RCX | — | 19/21 | — | — | 4/10 | 79/52 | ||||
2 | LAD, LCX, RCX | LAD, RCX | 22/31 | — | — | 5/18 | 77/42 | ||||
3 | LAD, LCX, RCX | — | 11/21 | — | — | 3/14 | 73/33 | ||||
4 | LAD, RCX | LAD, RCX | 24/40 | — | — | 9/16 | 63/60 | ||||
5 | RCX | RCX | 15/22 | — | — | 1/11 | 93/50 | ||||
6 | LAD, RCX | — | 15/28 | — | — | 8/16 | 47/43 | ||||
7 | RCX | — | 20/30 | — | — | 7/15 | 65/50 | ||||
8 | RCX | — | 7/22 | — | — | 2/9 | 71/59 | ||||
9 | RCX | — | 8/26 | — | — | 3/9 | 63/65 | ||||
10 | RCX | — | 8/14 | — | — | 3/8 | 63/43 | ||||
Mean ± SE | 14.9 ± 2.1/25.5 ± 2.4 | 4.5 ± 0.9*/12.6 ± 1.2* | 69 ± 4*/ 50 ± 3* |
↵* P < 0.01 vs. group I.